Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

about

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

Item

http://www.wikidata.org/entity/Q52312118

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

@en

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

@nl

type

Item

label

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

@en

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

@nl

prefLabel

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

@en

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

@nl

P1476

Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.

@en

P2093

Avner Friedman

http://www.w3.org/2001/XMLSchema#string

Balveen Kaur

http://www.w3.org/2001/XMLSchema#string

Ji Young Yoo

http://www.w3.org/2001/XMLSchema#string

Jianhua Yu

http://www.w3.org/2001/XMLSchema#string

Joseph Liu

http://www.w3.org/2001/XMLSchema#string

Michael A Caligiuri

http://www.w3.org/2001/XMLSchema#string

Tae Jin Lee

http://www.w3.org/2001/XMLSchema#string

Yangjin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

Advantages and applications of CAR-expressing natural killer cells

Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?

Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects.

P31

scholarly article

P356

10.1073/PNAS.1715295115

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29686060

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5948955

http://www.w3.org/2001/XMLSchema#string